Background: Hepatitis B virus (HBV) infection is increasing globally, posing a serious public health problem. Hepatitis B virus (HBV) infection and mortality are among the leading causes of death worldwide. Concerns for public health are amplified by the fact that about a third of the world's population is afflicted with HBV. HBV infection may result in cirrhosis, hepatocellular cancer, or both (HCC).
Immunization is the most cost-effective strategy available worldwide for controlling and preventing hepatitis B in terms of benefit-cost ratio. Objective: This review article discusses the most critical components of the HBV vaccine and the most efficient strategies for increasing HBV vaccination.
Saber, M. A., Sarhan, H. A., Fouad, Y. M., Elsayed, M. M., & Hassnine, A. A. (2022). Overview on Hepatitis B vaccination. The Egyptian Journal of Hospital Medicine, 86(1), 696-699. doi: 10.21608/ejhm.2022.215573
MLA
Mona Ali Saber; Hatem Abdul-Monsef Sarhan; Yasser Mahrous Fouad; Mahmoud MA Elsayed; Alshymaa Ahmed Hassnine. "Overview on Hepatitis B vaccination", The Egyptian Journal of Hospital Medicine, 86, 1, 2022, 696-699. doi: 10.21608/ejhm.2022.215573
HARVARD
Saber, M. A., Sarhan, H. A., Fouad, Y. M., Elsayed, M. M., Hassnine, A. A. (2022). 'Overview on Hepatitis B vaccination', The Egyptian Journal of Hospital Medicine, 86(1), pp. 696-699. doi: 10.21608/ejhm.2022.215573
VANCOUVER
Saber, M. A., Sarhan, H. A., Fouad, Y. M., Elsayed, M. M., Hassnine, A. A. Overview on Hepatitis B vaccination. The Egyptian Journal of Hospital Medicine, 2022; 86(1): 696-699. doi: 10.21608/ejhm.2022.215573
)
View on SCiNiTO